153 related articles for article (PubMed ID: 24517415)
1. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B.
Wu H; Zhao G; Qian F; Liu K; Xie J; Zhou H; Xu J; Xu Y; Han Y; Xie Q; Wang H
Liver Int; 2015 Feb; 35(2):473-81. PubMed ID: 24517415
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.
Sonneveld MJ; Wong VW; Woltman AM; Wong GL; Cakaloglu Y; Zeuzem S; Buster EH; Uitterlinden AG; Hansen BE; Chan HL; Janssen HL
Gastroenterology; 2012 Mar; 142(3):513-520.e1. PubMed ID: 22108195
[TBL] [Abstract][Full Text] [Related]
3. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
Wei L; Wedemeyer H; Liaw YF; Chan HL; Piratvisuth T; Marcellin P; Jia J; Tan D; Chow WC; Brunetto MR; Diago M; Gurel S; Morozov V; He H; Zhu Y; Wat C; Surujbally B; Thompson AJ
PLoS One; 2018; 13(7):e0199198. PubMed ID: 30016335
[TBL] [Abstract][Full Text] [Related]
4. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.
Holmes JA; Nguyen T; Ratnam D; Heerasing NM; Tehan JV; Bonanzinga S; Dev A; Bell S; Pianko S; Chen R; Visvanathan K; Hammond R; Iser D; Rusli F; Sievert W; Desmond PV; Bowden DS; Thompson AJ
J Gastroenterol Hepatol; 2013 May; 28(5):861-6. PubMed ID: 23301835
[TBL] [Abstract][Full Text] [Related]
5. Impact of IL28B and
Domagalski K; Pawłowska M; Zaleśna A; Pilarczyk M; Rajewski P; Halota W; Tretyn A
World J Gastroenterol; 2016 Nov; 22(41):9186-9195. PubMed ID: 27895405
[TBL] [Abstract][Full Text] [Related]
6. Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon.
Boglione L; Cusato J; Allegra S; Esposito I; Patti F; Cariti G; Di Perri G; D'Avolio A
Antiviral Res; 2014 Feb; 102():35-43. PubMed ID: 24316030
[TBL] [Abstract][Full Text] [Related]
7. Association of IPS1 polymorphisms with peginterferon efficacy in chronic hepatitis B with HBeAg-positive in the Chinese population.
Wang H; Wu H; Bao S; Xiang X; Zhao G; Liu K; Li F; Xu Y; An B; Zhou H; Lu J; Xie Q
Infect Genet Evol; 2015 Apr; 31():161-8. PubMed ID: 25640825
[TBL] [Abstract][Full Text] [Related]
8. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.
Lampertico P; Viganò M; Cheroni C; Facchetti F; Invernizzi F; Valveri V; Soffredini R; Abrignani S; De Francesco R; Colombo M
Hepatology; 2013 Mar; 57(3):890-6. PubMed ID: 22473858
[TBL] [Abstract][Full Text] [Related]
9. No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.
Heo NY; Lim YS; Lee W; Oh M; An J; Lee D; Shim JH; Kim KM; Lee HC; Lee YS; Suh DJ
Clin Mol Hepatol; 2014 Jun; 20(2):177-84. PubMed ID: 25032184
[TBL] [Abstract][Full Text] [Related]
10. The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infection.
Domagalski K; Pawłowska M; Zaleśna A; Tyczyno M; Skorupa-Kłaput M; Tretyn A; Halota W
Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):2025-33. PubMed ID: 24924923
[TBL] [Abstract][Full Text] [Related]
11. IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B.
Lee IC; Lin CH; Huang YH; Huo TI; Su CW; Hou MC; Huang HC; Lee KC; Chan CC; Lin MW; Lin HC; Lee SD
PLoS One; 2013; 8(2):e58071. PubMed ID: 23469142
[TBL] [Abstract][Full Text] [Related]
12. Genotype F of hepatitis B: response to interferon.
Venegas M; Poniachik J; Fuster F; Hurtado C; Villanueva RA; Brahm J
Antivir Ther; 2015; 20(4):453-6. PubMed ID: 25321866
[TBL] [Abstract][Full Text] [Related]
13. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population.
Li W; Jiang Y; Jin Q; Shi X; Jin J; Gao Y; Pan Y; Zhang H; Jiang J; Niu J
Liver Int; 2011 Sep; 31(8):1118-26. PubMed ID: 21745278
[TBL] [Abstract][Full Text] [Related]
14. Peginterferon α in the treatment of chronic hepatitis B.
Tseng TC; Kao JH; Chen DS
Expert Opin Biol Ther; 2014 Jul; 14(7):995-1006. PubMed ID: 24738850
[TBL] [Abstract][Full Text] [Related]
15. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
17. IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
Zhang Q; Lapalus M; Asselah T; Laouénan C; Moucari R; Martinot-Peignoux M; Bieche I; Estrabaud E; De Muynck S; Boyer N; Bedossa P; Vidaud M; Marcellin P; Lada O
J Viral Hepat; 2014 Jul; 21(7):525-32. PubMed ID: 24118626
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.
Jung YK; Kim JH; Ahn SM; Yang JW; Park SJ; Kim JW; Yeon JE; Kwon OS; Kim YS; Choi DJ; Kim JH; Byun KS
J Clin Gastroenterol; 2013 Aug; 47(7):644-50. PubMed ID: 23442843
[TBL] [Abstract][Full Text] [Related]
19. IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population.
Dong ZX; Zhou HJ; Xiang XG; Guo SM; Zhuang Y; Zhao GD; Xie Q
J Dig Dis; 2015 Feb; 16(2):90-7. PubMed ID: 25312023
[TBL] [Abstract][Full Text] [Related]
20. Single Nucleotide Polymorphism of Interferon Lambda-4 Gene is not Associated with Treatment Response to Pegylated Interferon in Thai Patients with Chronic Hepatitis B.
Limothai U; Wasitthankasem R; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(13):5515-9. PubMed ID: 26225703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
